Skip to content

Therapeutic effect of fully digitally manufactured occlusal splints using individual patient parameters electronically determined by means of the DMD-System® and digital determination of the therapeutic position vs. conventional stabilization splints -a clinical prospective randomized double-blind study-

Therapeutic effect of fully digitally manufactured occlusal splints using individual patient parameters electronically determined by means of the DMD-System® and digital determination of the therapeutic position vs. conventional stabilization splints -a clinical prospective randomized double-blind study-

Status
Active, not recruiting
Phases
Phase 4
Study type
Interventional
Source
DRKS
Registry ID
DRKS00025463
Enrollment
123
Registered
2021-06-07
Start date
2022-01-20
Completion date
Unknown
Last updated
2026-04-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

K07.6

Interventions

Group 1: Control group: Patients (diagnosed with arthropathy) receive a conventional stabilization splint, manufactured according to mean values. Prospective follow-up is planed over a period of 12 we

Sponsors

ZZMK (Carolinum) der Johann Wolfgang Goethe-Universität, Poliklinik für Zahnärztliche Prothetik
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to No maximum

Inclusion criteria

Inclusion criteria: - Arthropathy according to the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) - Indication for a stabilization splint - Natural, complete dentition (everywhere up to the second molar) or corresponding fixed dentures

Exclusion criteria

Exclusion criteria: - Pregnant women - Incapacitated patients (e.g. due to dementia) - Psychosomatic comorbidities - People with a removable denture in the upper or lower jaw - Indication for a positioning splint - Only myopathy without arthropathy - Acute events such as joint effusion or trauma - Addictions (alcohol, drugs, analgesics) - Pain disorders such as fibromyalgia syndrome, neuropathic pain, trigeminal neuralgia or atypical facial pain - Diseases and other criteria that generally make an MRI scan impossible: • Pacemaker • Neurostimulator or drug pump • Metal parts in the body (e.g. splinters, clips or staples after operations, cochlear implants) that prevent an MRI • Fear of tight spaces (claustrophobia) • Severely impaired cardiovascular health disorders.

Design outcomes

Primary

MeasureTime frame
The percentage of the VAS (Visual Analog Scale)-difference for quantifying the pain reduction before and after splint therapy is assessed. Measurement times: Before therapy, after 3 weeks, 6 weeks and 12 weeks.

Secondary

MeasureTime frame
1. The oral health-related quality of life is measured (Questionnaire OHIP-G 14). 2. The change in the condyle-disc-fossa-relation achieved by the therapeutic position is measured on the basis of the metric evaluation of magnetic resonance images. Depending on further questionnaires, following parameters are assessed: 3. pain-related symptoms ("Diagnostic Criteria for Temporomandibular Disorders-Symptom Questionnaire", "Pain representation", "Jaw Functional Limitation Scale (JFLS-8)," Fonseca-G ", Pain reduction using Numerical Analog Scales (GCS)), 4. the sleep quality (Pittsburgh Sleep Quality Index (PSQI)), 5. the activities during sleep and while awake ((Oral Behaviors Checklist) (OBC)), 6. the wearing comfort of the splints (Numerical Rating Scale = NRS).

Countries

Germany

Contacts

Public ContactTugba Zahn

ZZMK (Carolinum) der Johann Wolfgang Goethe-Universität, Poliklinik für Zahnärztliche Prothetik

Zahn@med.uni-frankfurt.de+49 (0) 69 6301-6736

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: May 1, 2026